| Dr William Robert Mundle, MD FRCSC | |
|
601 John St Ste N1100, Kalamazoo, MI 49007-5349 | |
| (269) 341-7887 | |
| Not Available |
| Full Name | Dr William Robert Mundle |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 32 Years |
| Location | 601 John St Ste N1100, Kalamazoo, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326648577 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bronson Methodist Hospital | 0244148633 | 598 |
News Archive
Rice University scientists have succeeded in analyzing transmembrane protein folding in the same way they study the proteins' free-floating, globular cousins.
Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen" for advanced basal cell carcinoma in an editorial in the New England Journal of Medicine.
More than 150 top scientists, researchers and public health experts from around the world will meet in Switzerland next week to present, debate and offer expert advice on cutting edge vaccine research and development, as well as vaccine policy and implementation.
NeoPharm, Inc. (Other OTC: NEOL.PK), announced today that it has reached a settlement agreement with Diosynth, RTP ("Diosynth"). As previously noted, NeoPharm reported that it had entered into various contractual arrangements with Diosynth to secure access to manufacturing capacity for the potential manufacture and regulatory advancement of Cintredekin Besudotox through early 2008.
› Verified 4 days ago
| Entity Name | Bronson Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417961137 PECOS PAC ID: 0244148633 Enrollment ID: O20031208000832 |
News Archive
Rice University scientists have succeeded in analyzing transmembrane protein folding in the same way they study the proteins' free-floating, globular cousins.
Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen" for advanced basal cell carcinoma in an editorial in the New England Journal of Medicine.
More than 150 top scientists, researchers and public health experts from around the world will meet in Switzerland next week to present, debate and offer expert advice on cutting edge vaccine research and development, as well as vaccine policy and implementation.
NeoPharm, Inc. (Other OTC: NEOL.PK), announced today that it has reached a settlement agreement with Diosynth, RTP ("Diosynth"). As previously noted, NeoPharm reported that it had entered into various contractual arrangements with Diosynth to secure access to manufacturing capacity for the potential manufacture and regulatory advancement of Cintredekin Besudotox through early 2008.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Robert Mundle, MD FRCSC 181 Essex Road, Tecumseh, ONTARIO N8N2K-5 Ph: () - | Dr William Robert Mundle, MD FRCSC 601 John St Ste N1100, Kalamazoo, MI 49007-5349 Ph: (269) 341-7887 |
News Archive
Rice University scientists have succeeded in analyzing transmembrane protein folding in the same way they study the proteins' free-floating, globular cousins.
Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen" for advanced basal cell carcinoma in an editorial in the New England Journal of Medicine.
More than 150 top scientists, researchers and public health experts from around the world will meet in Switzerland next week to present, debate and offer expert advice on cutting edge vaccine research and development, as well as vaccine policy and implementation.
NeoPharm, Inc. (Other OTC: NEOL.PK), announced today that it has reached a settlement agreement with Diosynth, RTP ("Diosynth"). As previously noted, NeoPharm reported that it had entered into various contractual arrangements with Diosynth to secure access to manufacturing capacity for the potential manufacture and regulatory advancement of Cintredekin Besudotox through early 2008.
› Verified 4 days ago
Dr. Amanda Keating Walker, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Suite N1200, Kalamazoo, MI 49007 Phone: 269-341-7979 Fax: 269-341-6261 | |
Paul I Berkowitz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 John Street, Box 42, Kalamazoo, MI 49007 Phone: 269-341-6417 Fax: 269-341-8743 | |
Malcolm Hamilton, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 601 John St, Suite N1200, Kalamazoo, MI 49007 Phone: 269-341-7979 Fax: 269-341-6261 | |
Dr. Benjamin Baines Mize, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 N Park St, Kalamazoo, MI 49007 Phone: 269-382-2500 Fax: 269-384-8617 | |
Jordan Wroblewski, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1521 Gull Rd, Kalamazoo, MI 49048 Phone: 269-226-6000 | |
Dr. Wendy L Bauer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2854 S 11th St, Kalamazoo, MI 49009 Phone: 269-345-6197 Fax: 269-345-9734 | |
Brandi L Boone, CNM Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 601 John St, Suite N1200, Kalamazoo, MI 49007 Phone: 269-341-7979 Fax: 269-341-6261 |